通过蛋白质冠状病毒辅助DNA立方体增强的寡核酸治疗药物的系统性大脑输送
Kyoung-Ran Kim1, Ji Hee Kang2, Hien Bao Dieu Thai1
1Chemical and Biological Integrative Research Center, Korea Institute of Science and Technology (KIST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul, 02792, Republic of Korea.
Small methods
|August 2, 2024
概括
研究人员开发了一个DNA纳米结构平台,用于向大脑输送寡核酸治疗药物. 这种立方体形的纳米结构 (D-Cb) 成功穿越了血脑屏障,并提供治疗载荷来治疗小鼠的大脑瘤.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 神经科学是一个神经科学.
背景情况:
- 系统性向大脑输送寡核酸治疗药物是治疗神经疾病的一个重大挑战.
- 传统的小分子药物对许多大脑疾病无效,需要新的治疗方法.
研究的目的:
- 开发一种蛋白质冠状病毒辅助平台,用于增强脑部输送寡核酸治疗药物.
- 研究DNA纳米结构在穿越血脑屏障 (BBB) 和向大脑组织输送治疗剂方面的潜力.
主要方法:
- 对DNA纳米结构进行查,以检测大脑的传递能力.
- 静脉注射DNA纳米结构的生物分布分析,重点是立方体形结构 (D-Cb).
- 在D-Cb上形成的蛋白冠的蛋白质组分析,以了解BBB透机制.
- 在体内评估D-Cb载有反感性寡核酸 (ASO) 用于小鼠多种质母细胞瘤 (GBM) 治疗.
主要成果:
- 一个立方体形的DNA纳米结构 (D-Cb) 证明了BBB的有效透和在大脑组织内的分布.
- 蛋白冠状分析表明,向内皮受体的配体调解D-Cb的大脑转细胞.
- 装载在D-Cb上的ASO有效地传递给脑瘤,降低目标基因的调节,并表现出抗瘤效应.
- 免费的ASO显示了可以忽略的脑部输送,突出显示了D-Cb平台的有效性.
结论:
- D-Cb纳米结构作为一个可行的平台,用于系统性脑部输送寡核酸治疗药物.
- 蛋白质冠状形成在使纳米结构能够穿越BBB方面发挥着至关重要的作用.
- 这一平台对治疗包括多形质母细胞瘤在内的脑疾病有前途.
相关概念视频
02:27DNA Base Pairing
Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...